Squarepoint Ops LLC Editas Medicine, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 92,713 shares of EDIT stock, worth $112,182. This represents 0.0% of its overall portfolio holdings.

Number of Shares

92,713

Previous 694,180 86.64%

Holding current value

$112,182

Previous $3.24 Million 90.25%

% of portfolio

0.0%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.39 - $5.96 $2.04 Million - $3.58 Million	-601,467 Reduced 86.64%	92,713 $316,000
Q2 2024 Aug 14, 2024	SELL	$4.67 - $7.28 $953,968 - $1.49 Million	-204,276 Reduced 22.74%	694,180 $3.24 Million
Q1 2024 May 15, 2024	BUY	$7.03 - $11.07 $2.23 Million - $3.51 Million	316,678 Added 54.43%	898,456 $6.67 Million
Q4 2023 Feb 14, 2024	BUY	$6.25 - $11.11 $3.26 Million - $5.8 Million	522,115 Added 875.11%	581,778 $5.89 Million
Q2 2023 Aug 14, 2023	BUY	$6.36 - $11.47 $379,456 - $684,334	59,663 New	59,663 $491,000
Q4 2022 Feb 14, 2023	SELL	$8.32 - $13.21 $25,608 - $40,660	-3,078 Reduced 8.43%	33,444 $296,000
Q3 2022 Nov 14, 2022	BUY	$12.16 - $19.42 $444,107 - $709,257	36,522 New	36,522 $447,000
Q1 2022 May 16, 2022	SELL	$14.08 - $27.63 $518,228 - $1.02 Million	-36,806 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$26.55 - $40.57 $539,814 - $824,869	20,332 Added 123.42%	36,806 $977,000
Q3 2021 Nov 15, 2021	BUY	$39.27 - $72.94 $646,933 - $1.2 Million	16,474 New	16,474 $677,000
Q1 2021 May 17, 2021	SELL	$39.71 - $90.58 $159,634 - $364,131	-4,020 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$27.07 - $84.35 $494,271 - $1.54 Million	-18,259 Reduced 81.96%	4,020 $282,000
Q3 2020 Nov 16, 2020	BUY	$28.06 - $37.16 $392,194 - $519,385	13,977 Added 168.36%	22,279 $625,000
Q2 2020 Aug 14, 2020	BUY	$18.5 - $34.34 $153,587 - $285,090	8,302 New	8,302 $246,000
Q1 2020 May 15, 2020	SELL	$14.88 - $32.78 $127,566 - $281,022	-8,573 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$19.49 - $32.63 $167,087 - $279,736	8,573 New	8,573 $254,000
Q3 2019 Nov 14, 2019	SELL	$22.49 - $26.81 $362,089 - $431,641	-16,100 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$20.48 - $27.76 $1.65 Million - $2.23 Million	-80,400 Reduced 83.32%	16,100 $398,000
Q1 2019 May 15, 2019	BUY	$19.43 - $26.41 $236,676 - $321,700	12,181 Added 14.45%	96,500 $2.36 Million
Q4 2018 Feb 14, 2019	BUY	$18.19 - $31.79 $509,665 - $890,724	28,019 Added 49.77%	84,319 $1.92 Million
Q3 2018 Nov 14, 2018	BUY	$27.65 - $38.39 $128,240 - $178,052	4,638 Added 8.98%	56,300 $1.79 Million
Q2 2018 Aug 14, 2018	BUY	$31.4 - $41.01 $812,066 - $1.06 Million	25,862 Added 100.24%	51,662 $1.85 Million
Q1 2018 May 15, 2018	BUY	$29.84 - $44.08 $354,469 - $523,626	11,879 Added 85.33%	25,800 $855,000
Q4 2017 Feb 14, 2018	BUY	$21.89 - $31.34 $304,730 - $436,284	13,921	13,921 $428,000

Others Institutions Holding EDIT

# of Institutions

248

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $83.2M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Editas Medicine, Inc. Transaction History